| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | Chief Financial Officer | $801K | Mar 31, 2025 | ||
| EDIT | Editas Medicine, Inc. | Evp, Chief Financial Officer | $193K | -$7.03K | -3.52% | Mar 8, 2025 |
| AVEO | AVEO PHARMACEUTICALS, INC. | Chief Financial Officer | Jan 19, 2023 | |||
| XAIR | Beyond Air, Inc. | Director | Nov 4, 2025 | |||
| BBLG, BBLGW | Bone Biologics Corp | Director | Sep 18, 2023 | |||
| SABS, SABSW | SAB Biotherapeutics, Inc. | Director | Jul 15, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|